# Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma

> **NCT00185861** · PHASE1 · COMPLETED · sponsor: **Stanford University** · enrollment: 12 (actual)

## Conditions studied

- Brain Cancer

## Interventions

- **DRUG:** Arsenic Trioxide
- **PROCEDURE:** Stereotactic radiosurgery

## Key facts

- **NCT ID:** NCT00185861
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2008-01
- **Final completion:** 2009-04
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2009-04-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00185861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00185861, "Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00185861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*